Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing / Lanza, G.A., Fox, K., Crea, F.
IF current inhibition: cellular basis and physiology / Mangoni, M.E., Marger, L., Nargeot, J.
Heart rate reduction by pharmacological IF current inhibition / Cargnoni, A. ... [et al.]
Clinical perspectives of heart rate slowing for coronary event reduction and heart failure / Danchin, N., Kadri, Z.
Clinical effect of 'pure' heart rate slowing with a prototype IF current inhibitor: placebo-controlled experience with ivabradine / Borer, J.S.
Heart rate slowing versus other pharmacological antianginal strategies. Results of comparative studies / Diaz, A., Tardif, J.-C.
Novel IF current inhibitor ivabradine: safety considerations / Savelieva, I., Camm, A.J.
Heart rate slowing for myocardial dysfunction/heart failure. Rationale and preclinical studies / Mulder, P., Thuillez, C.
Future directions: what data do we need? / Tendera, M.
OBNB doesn't sell books, but you may be able to find a copy at one of these websites:
Heart rate slowing by IF current inhibition. ISBN 9783805581608. Published by Karger in 2006. Publication and catalogue information, links to buy online and reader comments.
